|
Utility of the Lung Immune Prognostic Index (LIPI) in prognostication and disease control prediction in advanced NSCLC patients treated with nivolumab. |
|
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Merck Sharp & Dohme; PharmaMar |
|
|
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Roche/Genentech; Takeda |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - MTrap; Nasasbiotech |
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Leo Pharma; Lilly; Merck; MSD; Novartis; Pfizer; Roche |
Research Funding - Merck; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; PharmaMar; Pierre Fabre; Roche |
|
Francisco J. Afonso Afonso |
Consulting or Advisory Role - AstraZeneca Spain; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Takeda |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pfizer |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche; Sanofi |
Speakers' Bureau - Astellas Oncology; AstraZeneca; Bayer; Boehringer Ingelheim; Ipsen; Lilly; Novartis; Roche; Sanofi |
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche |
|
Cristina Azpitarte Raposeiras |
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology |
Speakers' Bureau - AstraZeneca; Lilly; PharmaMar; Pierre Fabre; Roche |
Travel, Accommodations, Expenses - Lilly; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; MSD Oncology; Roche/Genentech; Takeda |
|
Joaquín Mosquera Martínez |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Roche |
Travel, Accommodations, Expenses - MSD; Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Guillermo Alonso-Jáudenes Curbera |
No Relationships to Disclose |
|
|
Honoraria - Bayer; Novartis; Pfizer |
Consulting or Advisory Role - Bayer |
Travel, Accommodations, Expenses - Astellas Pharma |